Ravi Vij, MD, MBA, Washington University Medical School, St. Louis, MO, compares the validity of the Simplified Early Relapse in Multiple Myeloma (S-ERMM) score in comparison to other currently used tools to predict early relapse in multiple myeloma. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.